Business Description
Celcuity Inc
NAICS : 541714
SIC : 2834
ISIN : US15102K1007
Description
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.68 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | -0.56 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -40.7 | |||||
3-Year EPS without NRI Growth Rate | -43 | |||||
3-Year FCF Growth Rate | -47.8 | |||||
3-Year Book Growth Rate | 69 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.56 | |||||
9-Day RSI | 57.47 | |||||
14-Day RSI | 54.75 | |||||
6-1 Month Momentum % | 6.09 | |||||
12-1 Month Momentum % | 47.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.23 | |||||
Quick Ratio | 11.23 | |||||
Cash Ratio | 10.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35.3 | |||||
Shareholder Yield % | -2.06 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -61.24 | |||||
ROA % | -43.71 | |||||
ROIC % | -5421.78 | |||||
ROC (Joel Greenblatt) % | -7688.69 | |||||
ROCE % | -43.36 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.77 | |||||
Price-to-Tangible-Book | 3.77 | |||||
EV-to-EBIT | -6.37 | |||||
EV-to-EBITDA | -6.38 | |||||
EV-to-FCF | -7.44 | |||||
Price-to-Net-Current-Asset-Value | 3.8 | |||||
Price-to-Net-Cash | 4.1 | |||||
Earnings Yield (Greenblatt) % | -15.7 | |||||
FCF Yield % | -10.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CELC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Celcuity Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -2.77 | ||
Beta | -0.14 | ||
Volatility % | 64.52 | ||
14-Day RSI | 54.75 | ||
14-Day ATR ($) | 0.721343 | ||
20-Day SMA ($) | 15.4485 | ||
12-1 Month Momentum % | 47.78 | ||
52-Week Range ($) | 8.389 - 22.188 | ||
Shares Outstanding (Mil) | 35.1 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Celcuity Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Celcuity Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Celcuity Inc Frequently Asked Questions
What is Celcuity Inc(CELC)'s stock price today?
The current price of CELC is $16.41. The 52 week high of CELC is $22.19 and 52 week low is $8.39.
When is next earnings date of Celcuity Inc(CELC)?
The next earnings date of Celcuity Inc(CELC) is 2024-08-09 Est..
Does Celcuity Inc(CELC) pay dividends? If so, how much?
Celcuity Inc(CELC) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |